galactosamine has been researched along with ellagic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, WS; Gu, L; Jiang, CH; Liu, Y; Sun, LC; Sun, XF; Xu, Q; Zhou, H | 1 |
1 other study(ies) available for galactosamine and ellagic acid
| Article | Year |
|---|---|
Ellagic acid protects Lipopolysaccharide/D-galactosamine-induced acute hepatic injury in mice.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Ellagic Acid; Galactosamine; Heme Oxygenase-1; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; NF-kappa B; Protective Agents; Tumor Necrosis Factor-alpha | 2014 |